About 260MG Paclitaxel Injection IP
Discover unparalleled value with Paclitax 260MG Paclitaxel Injection IP-an outstanding treatment option at a reduced price for those exploring advanced anticancer chemotherapy solutions. This preservative-free masterpiece features a supreme composition of Paclitaxel 260mg in a clear, colourless to pale yellow liquid form. Designed for intravenous infusion only, it stands out with its compatibility for dilution and use with 0.9% Sodium Chloride or 5% Dextrose. Suitable for adults, Paclitax is indicated for ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma. Always administered by healthcare professionals.
Exceptional Therapeutic Application and Commercial Uses
260MG Paclitaxel Injection IP is widely utilized in hospitals and cancer care facilities, administered by healthcare professionals for superior efficacy. Intended for adult patients, this injectable, plant-derived anti-neoplastic agent is a preferred choice in commercial oncology treatment for ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma. Paclitax offers remarkable reliability in large-scale plant settings for consistent supply and trusted results.
Sample Policy, Supply Details, and Export Logistics
We offer a generous sample policy to facilitate product evaluation by potential buyers and healthcare organizations. Our robust supply ability ensures that bulk orders are efficiently dispatched, with shipments arriving promptly across main export markets such as Asia, Africa, and the Middle East. All orders are securely packaged in glass vials and shipped with careful consideration of temperature and light, ensuring safe arrival and optimal product integrity upon dispatching.
FAQ's of 260MG Paclitaxel Injection IP:
Q: How should 260MG Paclitaxel Injection IP be administered?
A: This injection must be diluted with either 0.9% Sodium Chloride or 5% Dextrose prior to use and administered as an intravenous infusion by qualified healthcare professionals.
Q: What cancers is Paclitax 260MG Paclitaxel Injection IP used to treat?
A: Paclitaxel Injection IP is indicated for the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma.
Q: When is the optimal timing for administering Paclitaxel?
A: The timing and frequency should be determined by a physician, based on the patient's specific chemotherapy regimen and individual health circumstances.
Q: Where should 260MG Paclitaxel Injection IP be stored?
A: Store the injection below 25C and protect it from light to preserve quality and effectiveness.
Q: What is the process for ordering and receiving this product internationally?
A: Orders can be placed through authorized suppliers or traders, with prompt dispatching and secure shipping to various main export markets, ensuring timely arrival.
Q: What are the benefits of the preservative-free formulation?
A: A preservative-free formulation reduces the risk of allergic reactions and makes it suitable for patients sensitive to preservatives, ensuring safer administration.